from24/7 Wall St.
13 hours agoIDEXX Laboratories Jumps 15% on Q3 Earnings Beat
The growth came from both major segments. Companion Animal Group (CAG) diagnostics recurring revenue grew 11% reported and 10% organically. Laboratory and Professional Services (LPS) revenue climbed 17% reported and 14% organically. CEO Jay Mazelsky highlighted the impact of new product launches, specifically IDEXX Cancer Dx, new Catalyst specialty tests for Pancreatic Lipase and Cortisol, and inVue Dx, which he described as delivering "powerful new diagnostic capabilities" with "strong execution and global customer adoption."
Business



